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Abstract
Periodontitis is a biofilm-induced chronic inflammatory disease that causes gingival inflammation and
attachment loss. Destruction of periodontal tissue is a consequence of host immune inflammatory
responses induced by periodontal microorganisms. Wnt5a is strongly associated with inflammatory
responses and shown by several studies to be involved in inflammatory diseases including periodontitis.
sFRP5 is a homolog of Wnt5a receptor, frizzled protein. sFRP5 is a known inhibitor of Wnt5a signaling. To
investigate the correlation of Wnt5a and sFRP5 in periodontitis and healthy tissues, experiments were set
up using both clinical specimens and further investigation with stimulations of human gingival epithelial
cells (HGECs). Wnt5a and sFRP5 mRNA expression and protein levels were studied by
immunohistochemistry, quantitative real time PCR, and ELISA. Results showed localization of Wnt5a and
sFRP5 in periodontal tissue and higher level of Wnt5a expression in periodontitis group than in healthy
group and vice versa for sFRP5 expression. LPS from P. gingivalis or E. coli induced Wnt5a expression
and reduced sFRP5 expression. Moreover, sFRP5 mediated anti-inflammatory effects by inhibiting IL-8
production in HGECs. In conclusion, inverse correlation of Wnt5a and sFRP5 expression was shown for
the first time and human gingival epithelial cells were also proved to express both Wnt5a and sFRP5.
Wnt5a appears to be an important target for intervention in periodontitis and sFRP5 is likely a promising
therapeutic compound.
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ABSTRACT
Periodontitis is a biofilm-induced chronic inflammatory disease that causes gingival
inflammation and attachment loss. Destruction of periodontal tissue is a consequence of host
immune inflammatory responses induced by periodontal microorganisms. Wnt5a is strongly
associated with inflammatory responses and shown by several studies to be involved in
inflammatory diseases including periodontitis. sFRP5 is a homolog of Wnt5a receptor,
frizzled protein. sFRP5 is a known inhibitor of Wnt5a signaling. To investigate the correlation
of Wnt5a and sFRP5 in periodontitis and healthy tissues, experiments were set up using
both clinical specimens and further investigation with stimulations of human gingival
epithelial cells (HGECs). Wnt5a and sFRP5 mRNA expression and protein levels were
studied by immunohistochemistry, quantitative real time PCR, and ELISA. Results showed
localization of Wnt5a and sFRP5 in periodontal tissue and higher level of Wnt5a expression
in periodontitis group than in healthy group and vice versa for sFRP5 expression. LPS from
P. gingivalis or E. coli induced Wnt5a expression and reduced sFRP5 expression. Moreover,
sFRP5 mediated anti-inflammatory effects by inhibiting IL-8 production in HGECs. In
conclusion, inverse correlation of Wnt5a and sFRP5 expression was shown for the first time
and human gingival epithelial cells were also proved to express both Wnt5a and sFRP5.
Wnt5a appears to be an important target for intervention in periodontitis and sFRP5 is likely a
promising therapeutic compound.

LITERATURE REVIEW
Introduction
It is documented that more than 47% of the adult U.S. population suffers from periodontitis
and even up to 64% of adults aged 65 years and older had either moderate or severe
periodontitis [1]. Considering this high prevalence, it is important to investigate the
pathogenesis of periodontitis and develop effective treatments.
The inflammatory process is important in host immune defense and occurs in many parts
of the body. Inflammation helps defend against pathogens and takes part in wound healing.
As soon as the body encounters injury or infection, acute inflammation arises. However, if
the infection persists, chronic inflammation will ensue. A good example is the oral cavity.
Microorganisms are always present which can cause inflammatory response in the form of
gingivitis. Gingivitis is a reversible condition and affects only the gingival tissue, whereas the
underlying alveolar bone remains intact. In cases that there are other contributing factors, for
example, compromised host responses or intense microbial challenge, then gingivitis may
transition to periodontitis. Periodontitis is a biofilm-induced chronic inflammatory disease that
causes gingival inflammation and attachment loss [2]. Destruction of periodontal tissue is a
consequence of host immune inflammatory responses induced by periodontal
microorganisms. In the past, researchers showed that bacteria have a major role in the
pathogenesis of periodontitis [3, 4]. Later, the important role of host immune responses
contributing to disease progression has been investigated and confirmed [5, 6]. Hereditary
factors, systemic conditions and environmental factors were also shown to be involved [7].
The pathogenesis of periodontitis involves complex interactions between the microbial
challenge and host response that alters connective tissue and bone metabolism. In biofilm,
numerous bacterial strains reside. In the past, employing culturing techniques, a few bacteria
have been designated as periodontal pathogens. These bacteria constitute the so-called “red
complex” and include Tannerella forsythia, Porphyromonas gingivalis, and Treponema
denticola [8]. These three major strains of bacteria were thought to contribute to progression

of periodontitis. However, the advent of culture-independent, molecular-based methods of
bacterial identification has changed our understanding of the bacterial composition of the
periodontal region [2]. Nowadays, it is widely accepted that periodontitis is not caused by
single or a limited group of pathogens, but rather caused by polymicrobial synergy and
dysbiosis [9].
According to the polymicrobial synergy and dysbiosis (PSD) model, several kinds of
bacteria exhibit synergistic interactions that promote colonization, persistence, or virulence
orchestrated by keystone pathogens. P. gingivalis is a keystone pathogen that modulates the
host response and tips the balance from homeostasis to dysbiosis which enables only
certain kinds of bacteria to thrive and persist in the host. Inflammation has a major role that
selects members of bacterial community in the way that only inflammophilic bacteria can
survive. These bacteria are not destroyed by inflammation but fed on inflammatory
breakdown products as a source of nutrients. Therefore, this selective mechanism causes
the flourishing of inflammophilic bacteria which helps perpetuate tissue destruction that
finally loops back to serve as nutrient source for these bacteria, thereby generating a vicious
cycle [10].
Bacterial antigens, LPS, and toxins from biofilm stimulate host immune response. Once
stimulated, immune cells such as PMN, and humoral and cell-mediated response are
directed to reduce the bacterial challenge. This results in the production of inflammatory
mediators such as cytokines, chemokines, prostaglandins and proteolytic enzymes that alter
connective tissue and bone metabolism. If host immune system cannot cause resolution of
these inflammatory processes, then periodontal inflammation and periodontal damage will
follow[7].
The Wnt signaling protein family has a significant role in the developmental events of
multicellular organisms. Wnts is a large family of cysteine-rich secreted ligands that are
essential in the regulation of embryogenesis, development, proliferation, polarity, migration,
and invasion. Historically, there are two groups of Wnt proteins; the group that activates the

beta-catenin-dependent pathway (canonical) and the group that activates beta-cateninindependent pathway (non-canonical). Wnt1, Wnt3, Wnt3a, and Wnt7a are the canonical
Wnts which stabilize beta-catenin, while Wnt5a, Wnt5b, Wnt6, Wnt7b and Wnt11 are the
non-canonical Wnts[11]. However, some Wnt proteins have both canonical and noncanonical properties – for example, Wnt5a, which is considered a non-canonical Wnt, was
found to be able to induce secondary axis formation when the receptor Fz5 was present[12].
Therefore, some non-canonical Wnts may initiate canonical Wnt signaling when bound to
specific Wnt receptors.
Of all the wingless proteins, Wnt5a is particularly interesting. It is known to have significant
roles in the development process of various organs and postnatal functions. Recent reports
demonstrated that abnormalities in Wnt5a signaling are involved in cancers, inflammatory
diseases, and metabolic diseases[13].
Wnt5a is strongly associated with inflammatory responses. As stated above, Wnt5a
induces inflammatory process through non-canonical pathway. There are several studies
supporting this statement. An important study in Drosophila by Gordon’s group is considered
to be the first direct evidence of the function of Wnt pathway in inflammation and immunity.
They demonstrated that the Drosophila Wnt protein family member WntD is upregulated in
the fly via Toll/nuclear factor-kB (NF-kB) signaling and shown to be involved in antibacterial
defense against Listeria monocytogenes in a septic fly model[14]. Later on, Blumenthal’s
study in humans also demonstrated that Toll/NF-kB is required for the upregulation of Wnt5a
in response to microbial challenge [15]. Furthermore, this study also demonstrated that
Wnt5a upregulates the microbially-induced IL-12 response of antigen-presenting cells and
IFN-γ production by mycobacterial antigen-stimulated T-cells, illustrating a functional
involvement in the antimicrobial defense. This suggested the involvement of Wnt signaling in
innate and adaptive immunity to infections.
Recent study by Divaris et al also suggested significance of Wnt5a in pathology of chronic
periodontitis. They presented the results of a genome-wide association study of chronic

periodontitis and detected association of Wnt5a with severe chronic periodontitis[16]. These
findings indicate that wnt5a may be involved in inflammatory diseases and thus might be an
attractive candidate for therapeutic intervention.
Frizzled protein is a surface receptor for Wnt proteins. From 10 Fzs, Wnt5a signaling can
be mediated through at least Fz3, Fz4, Fz5 and Fz8[17]. It is suggested that Wnt5a regulates
cellular functions by binding to several Fzs. The soluble frizzled related protein is a family of
soluble proteins that are structurally related to Frizzled (Fz) proteins, the serpentine
receptors that mediate the extensively used cell-cell communication pathway involving Wnt
signaling. Because of their homology with the Wnt-binding domain on the Fz receptors,
sFRPs sequester Wnt proteins in the extracellular space and prevent Wnt from binding to
their receptors. They have therefore been characterized as antagonists that bind to Wnt
proteins to prevent signal activation[18]. The soluble frizzled related protein (sFRP)-5 is a
known inhibitor of wnt5a signaling[19].
Dominik and colleagues measured Wnt5a and sFRP5 serum concentrations in lean control
subjects and patients with obesity. They found that pro-inflammatory Wnt5a was not
measurable in any serum sample of lean control subjects. In patients with obesity, however,
Wnt5a was significantly upregulated consistent with low-grade inflammation in such subjects.
sFRP5 was detected in both groups with no significant difference. Interestingly, after caloric
restriction, there was a significant increase in serum concentrations of sFRP5. Furthermore,
they found that adipose tissue macrophages of obese and type 2 diabetic human subjects
express wnt5a secreted by macrophage and inhibits differentiation of pre-adipocytes.
These recent findings suggest that Wnt5a might act as an important pro-inflammatory
molecule in low-grade inflammation of adipose tissue in obese humans, whereas sFRP5
may play an anti-inflammatory role [20]. Since both obesity and periodontitis are
inflammatory diseases, these studies prompted us to study the expression of Wnt5a and
sFRP5 in periodontitis tissue and healthy tissue in order to dissect the possible roles of

Wnt5a and sFRP5 in the periodontal tissue in health and disease. It should be noted that
knowledge about the expression and modulation of Wnt homologs in inflammatory settings,
such as periodontitis, is still limited. A study demonstrated that Wnt5a mRNA expression was
up-regulated in chronic periodontitis tissue as compared to healthy control tissue using RTPCR[21]. However, no study thus far has investigated how the expression of Wnt5a is
correlated with sFRP5 expression in periodontitis and healthy tissue. We expect that our
approach will advance the knowledge of Wnt5a and sFRP5 in the progression and
prevention of periodontitis and serve as a platform for the development of new therapies.
Materials and methods
Human samples
Human gingival tissues were obtained during routine periodontal surgeries and crownlengthening surgeries conducted on 69 physically healthy adults in the University of
Pennsylvania School of Dental Medicine Graduate Periodontics Clinic. Samples of gingival
tissues were obtained from 29 individuals without periodontal disease (control group) during
crown-lengthening surgery and 40 patients with generalized and localized moderate to
severe chronic periodontitis. The PD, CAL of the sampling sites was evaluated using a
periodontal probe (Hu-Friedy, Leimen, Germany). Research was performed under an
Institutional Review Board–approved protocol and all donors provided informed consent.
Immunohistochemistry
Gingival biopsy specimens were fixed in 4% paraformaldehyde and embedded in OCT
compound. Cryostat sections were cut at 8 µm and mounted on glass slides. The sections
were fixed in PFA for 10 minutes, washed with mixed solution of Phosphate buffered saline
(PBS) and 0.1% Tween 20 followed by solution of PBS and 0.1% TritonX-100. Final rinse
with PBS 15 minutes before incubation. Sections were stained using mouse monoclonal
antibody against human Wnt5a (clone6F2, Lsbio), rabbit polyclonal antibody against human
sFRP (Novus), followed by secondary reagents (Alexa Fluor 488–conjugated goat anti-rabbit

IgG or Alexa Fluor 594–conjugated goat anti-mouse IgG,; Life Technologies). The specificity
of staining was confirmed by using appropriate isotype controls or nonimmune rabbit IgG
followed by Alexa Fluor 488– or Alexa Fluor 594–conjugated anti-IgG. Images were captured
using a Nikon Eclipse NiE automated upright fluorescent microscope.
Quantitative real-time PCR (qPCR)
Total RNA was extracted from excised gingival tissue or cultured cells using the PerfectPure
RNA cell kit (5 Prime, Fisher) and quantified by spectrometry at 260 and 280 nm. The RNA
was reverse-transcribed using the High Capacity RNA-to-cDNA Kit (Life Technologies) and
qPCR with cDNA was performed using the Applied Biosystems 7500 Fast Real-Time PCR
System according to the manufacturer's protocol (Life Technologies). Data were analyzed
using the comparative (∆∆Ct) method. TaqMan probes, sense primers, and antisense
primers for detection and quantification of genes investigated in this paper were purchased
from Life Technologies.
Cell preparation and culture
Human gingival epithelial cells (HGECs) were prepared from clinically normal gingival tissue.
The tissues were treated overnight with Dulbecco’s modified minimal essential medium
(DMEM) containing 0.025% trypsin and 0.01% EDTA. After washing with PBS and
subsequent chopping into small pieces, the tissues were suspended in Epilife, containing
supplement S7 and penicillin–streptomycin– amphotericin B solution (all from Invitrogen).
The tissues were removed when the cells started to grow and were maintained until the cells
reached confluence. For the stimulation experiments, HGECs were seeded into a 12-well
culture plate. After 24 h of incubation, the attached cells were washed extensively with Epilife
and co-cultured with 100ng/mL of P. gingivalis LPS (Invivogen), 100ng/mL of E. coli LPS
(Invivogen), Wnt5a 300ng/ml (R&D) or sFRP5 500ng/ml (R&D) in Epilife containing
Supplement S7 for 12 h (gene expression assay) or 24 h (Chemokine assay).
Chemokine assay
The level of IL-8 in the supernatants of HGECs culture were determined by using

commercially available ELISA kits (eBioScience) according to the manufacturer’s instructions.
Statistical Analysis
Results were expressed as the mean ± standard error of the mean. When two groups were
compared, unpaired t test was used. Multiple comparisons were performed by ANOVAWilliams test was used for post hoc comparisons. A probability value <0.05 was considered
statistically significant.
Results
Localization of Wnt5a and sFRP5 in periodontal tissue
To determine the localization of Wnt5a and sFRP5 protein expression in periodontal tissue,
we performed immunohistochemistry of periodontal biopsy specimens. Expression of sFRP5
was much stronger in healthy tissue compared to diseased periodontal tissue (Fig. 1). In
contrast, Wnt5a expression was comparable in diseased and healthy tissue. Both Wnt5a and
sFRP5 were expressed in the epithelial layer but not in the connective tissue.
Gene expressions of Wnt5a and sFRP5 in human periodontal tissue
We next investigated the gene expressions of Wnt5a and sFRP5 in human periodontal tissue.
We found that sFRP5 expression was upregulated in healthy tissue relative to its
expression in diseased tissue (Fig. 2), consistent with our immunohistochemical
observations. On the other hand, Wnt5a expression was increased in periodontitis tissue as
compared with healthy tissue (Fig. 2). Although Wnt5a expressed comparably in both health
and diseased periodontal tissues in IHC, its mRNA expression was significantly upregulated
in diseased tissue.
Effects of LPS on Wnt5a and sFRP5 expression in HGECs
Although P. gingivalis LPS can induce inflammatory cytokine, it is not clear whether these
affect Wnt5a and sFRP5 expression. First, we isolated HGECs from healthy patient. Both
stimuli used, LPS from P. gingivalis or E. coli, induced Wnt5a expression and reduced
sFRP5 expression (Fig. 3).

sFRP5 inhibited chemokine production in HGECs
To determine whether sFRP5 mediates anti-inflammatory effects, HGECs were treated with
both Wnt5a and LPS in the presence or absence of sFRP5. Importantly, the production of
IL-8 in HGECs was significantly inhibited in the presence of sFRP5 (Fig. 4).
Discussion
Wnt5a is strongly associated with inflammatory responses as shown by several studies.
Wnt5a was found to be a proinflammatory molecule that stimulates inflammatory function of
antigen-presenting cells, such as macrophages[15, 21-23].
Interestingly, our immunofluorescent staining demonstrated that Wnt5a and sFRP5 were
expressed in epithelial layer of gingival tissues. Furthermore, Wnt5a and sFRP5 were colocalized. More pronounced expression of sFRP5 in healthy group than in periodontitis group
was observed; however, the expression level of Wnt5a was found to be similar in both
groups. Difference was noted in merged Wnt5a and sFRP5 images of periodontitis and
healthy group in a way that Wnt5a appeared to predominate over sFRP5 expression in
periodontitis group and vice versa in the healthy group. Periodontitis tissues in this
experiment were obtained from periodontal surgeries. These tissues were periodontally
treated previously, thus it is likely that inflammation was not as pronounced as in cases of
untreated periodontitis. This might explain why we did not detect an obvious difference in the
levels of Wnt5a expression between periodontitis and healthy group. Results from the
immunofluorescent study showed clearly that Wnt5a and Sfrp5 were expressed in the
epithelial layer.
This led to the next step of quantitative analysis of Wnt5a and sFRP5 mRNA expression
using qPCR in both groups. Wnt5a mRNA was shown to be significantly higher in
periodontitis group when compared to healthy group. sFRP5 mRNA expression, on the
contrary, was shown to be significantly higher in healthy group. These results confirm our
hypothesis that the expression of the proinflammatory Wnt5a is more pronounced in inflamed
tissues and expression of the anti-inflammatory sFRP5 is more pronounced in healthy

tissues. Our findings agree with Nanbara’s study [21], which showed significantly higher
Wnt5a mRNA expression in periodontitis tissues, although they did not examine the
expression of Wnt5a protein. Moreover, we are the first group that investigated the
expression of sFRP5 mRNA and protein in periodontitis and healthy gingival tissues.
In order to confirm our speculation that gingival epithelial cells express Wnt5a and sFRP5,
another qPCR experiment was set up. Results clearly demonstrated that Wnt5a and sFRP5
mRNA were expressed by human gingival epithelial cells. Furthermore, modulation of Wnt5a
and sFRP5 expression by periodontal bacteria was also investigated. Wnt5a mRNA was
highly upregulated in the presence of P. gingivalis when compared to unstimulated group
and E. coli challenged group. The significance of P. gingivalis in the pathogenesis of
periodontitis is well documented. P. gingivalis is a keystone pathogen in periodontitis which
subverts the host response and tips the balance from homeostasis to dysbiosis.
As shown by this study that Wnt5a mRNA was highly up-regulated in the presence of P.
gingivalis when compared to unstimulated group. In contrast, sFRP5 mRNA was suppressed
in the presence of P. gingivalis and E. coli.
As stated previously, Wnt5a was found to be involved in a large number of inflammatory
diseases. Kim’s group demonstrated up-regulation of inflammatory cytokines, for example,
IL-8, IL-6 etc. by Wnt5a in endothelial cells through the Wnt-Ca2+ signaling pathway[24]. IL8 is a chemokine which mainly attracts neutrophils to sites of inflammation. It is up-regulated
by pro-inflammatory cytokines such as TNF-α and IL-1, bacterial or viral products. Increased
expressions of IL-8 and neutrophil accumulation have been shown to be involved in the
pathology of periodontitis[25]. Another experiment was set up to study the level of IL-8
mRNA expression using qPCR. Human gingival epithelial cells challenged with Wnt5a or P.
gingivalis LPS showed more expression of IL-8 while P. gingivalis LPS combined with Wnt5a
triggered the most pronounced IL-8 mRNA expression. This demonstrates synergistic effect
of P. gingivalis LPS and proinflammatory Wnt5a in eliciting inflammation. In contrast, P.

gingivalis LPS combined with sFRP5 decreased expression of IL-8 mRNA compared to
stimulation with P. gingivalis LPS alone. This demonstrates antagonistic effect of P.
gingivalis LPS and anti-inflammatory sFRP5. ELISA experiment confirmed these results at
the cytokine protein level.
Overall, it’s shown from our study that Wnt5a and sFRP5 have important roles in
inflammatory process of periodontitis. Wnt5a usually stimulates non-canonical Wnt signaling
which consists of at least three different B-catenin-independent pathways, the Wnt/PCP,
Wnt/Ca2+, and Wnt/ROR2. Interestingly, CAMKII and PKC which are products from
Wnt/Ca2+ pathway have been shown to block the Wnt canonical pathway[26]. Moreover,
Wnt/ROR2 pathway also can inhibit the canonical pathway[27]. In periodontitis, canonical
pathway is known to regulate bone homeostasis. Activation of canonical pathway leads to
more bone formation; on the contrary, inhibition of this pathway leads to bone destruction[28,
29]. On the basis of the above-discussed findings, we can speculate that apart from the
ability of Wnt5a to enhance inflammation through non-canonical pathways, mediators
induced via non-canonical pathways can also contribute to blockage of canonical pathway
and thus lead to further bone destruction.
Ouchi’s group conducted experiment in sFRP5 knockout mice, which were put on highcalorie diet. They observed systemic metabolic dysfunction and severe adipose tissue
inflammation. However, administration of sFRP5 improved metabolic function and downregulated adipose tissue inflammation[19]. A similar approach could be applied to the
treatment of periodontitis. Our study found higher level of sFRP5 in healthy gingival tissues
when compared to periodontitis tissues. sFRP5 also interferes with inflammatory chemokine
expression induced by Wnt5a or P. gingivalis LPS. Our results therefore suggest a role of
sFRP5 as a potential anti-inflammatory molecule in periodontitis.
Conclusion
We have shown for the first time an inverse correlation between Wnt5a and sFRP5 in
periodontal disease vs. health. We have moreover shown for the first time that both

molecules can be expressed by human gingival epithelial cells. Wnt5a appears to be an
important target for intervention in periodontitis and in this context, sFRP5 is likely a
promising therapeutic compound. This notion could be tested in future studies in preclinical
models, hopefully paving the way for clinical trials.
FIGURE LEGENDS
Figure. 1. Expression of Wnt5a and sFRP5 in sections of periodontal specimens. Periodontal
biopsy specimens from healthy and periodontitis patients were processed for
immunofluorescence and hematoxylin and eosin staining. Overlays of differential
interference contrast (DIC) and fluorescent images stained for wnt5a (red) and sFRP5
(green) are shown. Scale bar, 50 µm.
Figure. 2. Gene expression of Wnt5a and sFRP5 in periodontal tissue. The mRNA
expression levels were normalized against GAPDH mRNA. Data are means ± SD (N=9
healthy, N=8 periodontitis) . *p < 0.01.
Figure. 3. LPS increases Wnt5a expression and inhibites sFRP5 expression. HGECs were
stimulated for 12 h with P. gingivalis lipopolysaccharide (Pg LPS; 100ng/ml or 1 µg/mL), E. coli
LPS (Ec LPS; 100ng/ml or 1 µg/mL). Data are means ± SD (n = 5 sets of cells). *p < 0.01
compared with no pretreatment.
Figure. 4. sFRP5 inhibit production of chemokine IL-8 by Wnt5a and Pg LPS stimulation.
HGECs were pretreated for 1 h with sFRP5 (500ng/ml), followed by 12 h (mRNA) or 24 h
(chemokine assay) stimulation with medium only or with Pg LPS; 100ng/ml or Wnt5a (300ng/ml).
Subsequently, mRNA was collected for gene expression assay and culture supernatants were
collected for measuring IL-8 by ELISA. Data are means ± SD (n = 5 sets of cells). *p < 0.01.
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